NCT03731819View on ClinicalTrials.gov

Establishment of Abbreviated Pancreatobiliary MRI Protocol

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 5, 2018

Primary Completion Date

November 12, 2019

Study Completion Date

May 4, 2022

Conditions
Pancreas CystIntraductal Papillary Mucinous Neoplasm
Interventions
DIAGNOSTIC_TEST

Abbreviated PB MRI

Abbreviated PB MRI which targets table time of 10 minutes. For MRI acquisition, standard dose of commercially available MR contrast agent (Gadovist, Bayer, Germany) is used on weight-based dosing (0.1mmol/kg).

Trial Locations (1)

03080

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT03731819 - Establishment of Abbreviated Pancreatobiliary MRI Protocol | Biotech Hunter | Biotech Hunter